{"brief_title": "Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation", "brief_summary": "The purpose of this study is to determine the response rate of patients with refractory, relapsed or poor risk AML expressing FLT-3 activating mutations, when administered CEP-701 at a dosage of 60 mg 2 times a day.", "detailed_description": "This is an open-label study of CEP-701 in patients with refractory, relapsed, or poor risk AML expressing FLT-3 activating mutations. Patients who meet eligibility criteria will be enrolled at a dosage of 60 mg orally 2 times a day for 28 days (1 cycle). Upon completion of cycle 1, the dosage may be increased to 80mg 2 times a day or decreased to 40 mg 2 times a day, dependent upon response to 60 mg dosage.", "condition": ["Leukemia, Myeloid"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["CEP-701 60mg", "Cep-701 80mg", "Cep-701 40mg"], "description": ["60mg orally 2 times a day for 28 days", "80mg 2 times a day, dependent upon response to cycle 1", "40mg 2 times a day, dependent upon response to cycle 1"], "arm_group_label": ["Cycle 1", "Cycle 2", "Cycle 2b"], "criteria": "INCLUSION CRITERIA: - patient must have confirmed diagnosis of refractory or relapsed AML that expresses a FLT-3 mutation - patient must have life expectancy of more than 2 months - patient must be fully recovered from reversible side effects of previous therapy for cancer EXCLUSION CRITERIA: - total bilirubin, ALT or AST greater than 2 times upper limit of normal - patient <65 years of age with estimated creatinine clearance less than 60 mL/min; patient >65 years of age with serum creatinine > 1.5 times the upper limit of normal (ULN) - received any investigational drug within past 4 weeks - GI disturbance/malabsorption that may affect absorption of CEP-701 - HIV positive - received NSAID within prior 14 days - has active infection", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "FLT-3 mutation", "mesh_term": ["Leukemia", "Leukemia, Myeloid", "Leukemia, Myeloid, Acute"], "id": "NCT00030186"}